November 16, 2023
For weight management, tirzepatide (Zepbound) starts at 2.5 mg weekly and can be titrated at 4-week intervals to maintenance doses of 5 mg, 10 mg, or 15 mg weekly based on response and tolerability
3f), but not inguinal (Fig
Despite its advantages, its important to acknowledge GHK-Cus limitations when compared to traditional acne treatments in a research context: Limited Direct Evidence for Active Acne Vulgaris: While it has anti-inflammatory properties, there is currently limited direct clinical evidence specifically demonstrating GHK-Cu as a primary treatment for active acne breakouts (e.g., reducing papules, pustules, or cysts)
Gastroenterology ( Gastroenterology )
Measuring the activity of the histamine-degrading enzyme DAO and determining the DAO and histamine levels are not conclusive as individual methods, but they do help to confirm the suspected diagnosis of histamine intolerance